Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.0 - $4.45 $22,600 - $50,285
11,300 New
11,300 $22,000
Q2 2023

Aug 23, 2023

BUY
$3.08 - $9.55 $34,496 - $106,960
11,200 New
11,200 $36,000
Q1 2021

May 14, 2021

SELL
$15.31 - $26.52 $124,011 - $214,812
-8,100 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$16.84 - $27.59 $136,404 - $223,479
8,100 New
8,100 $215,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $198M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.